Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot study

M Chaudhry, M Alessandrini, J Rademan… - …, 2017 - Future Medicine
Aim: Therapy with low-dose amitriptyline is commonly used to treat painful diabetic
peripheral neuropathy. There is a knowledge gap, however, regarding the role of variable …
被引用次数：20 相关文章

Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot study

M Chaudhry, M Alessandrini… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Aim Therapy with low-dose amitriptyline is commonly used to treat painful diabetic
peripheral neuropathy. There is a knowledge gap, however, regarding the role of variable …

Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot study.

M Chaudhry, M Alessandrini… - …, 2017 - scholarlyexchange.childrensmercy …
AIM: Therapy with low-dose amitriptyline is commonly used to treat painful diabetic
peripheral neuropathy. There is a knowledge gap, however, regarding the role of variable …

Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot study

M Chaudhry, M Alessandrini, J Rademan… - …, 2017 - search.proquest.com
Aim: Therapy with low-dose amitriptyline is commonly used to treat painful diabetic
peripheral neuropathy. There is a knowledge gap, however, regarding the role of variable …
[PDF] semanticscholar.org

[PDF][PDF] Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot study.

M Chaudhry, M Alessandrini, J Rademan, TM Dodgen… - pdfs.semanticscholar.org
Aim: Therapy with low-dose amitriptyline is commonly used to treat painful diabetic
peripheral neuropathy. There is a knowledge gap, however, regarding the role of variable …

Impact of CYP2D6 Genotype on Amitriptyline Efficacy for the Treatment of Diabetic Peripheral Neuropathy: A Pilot Study

M Chaudhry, M Alessandrini, J Rademan… - …, 2017 - Taylor & Francis
Aim: Therapy with low-dose amitriptyline is commonly used to treat painful diabetic
peripheral neuropathy. There is a knowledge gap, however, regarding the role of variable …

Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot study

M Chaudhry, M Alessandrini, J Rademan, TM Dodgen… - 2017 - repository.up.ac.za
AIM: Therapy with low-dose amitriptyline is commonly used to treat painful diabetic
peripheral neuropathy. There is a knowledge gap, however, regarding the role of variable …
[PDF] academia.edu

[PDF][PDF] Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot study

M Chaudhry, M Alessandrini, J Rademan… - …, 2017 - academia.edu
Aim: Therapy with low-dose amitriptyline is commonly used to treat painful diabetic
peripheral neuropathy. There is a knowledge gap, however, regarding the role of variable …

Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot study

M Chaudhry, M Alessandrini, J Rademan… - …, 2017 - cir.nii.ac.jp
抄録< jats: p> Aim: Therapy with low-dose amitriptyline is commonly used to treat painful
diabetic peripheral neuropathy. There is a knowledge gap, however, regarding the role of …
[PDF] cyberleninka.org

[PDF][PDF] Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot study

M Chaudhry, M Alessandrini, J Rademan… - …, 2017 - cyberleninka.org
Aim: Therapy with low-dose amitriptyline is commonly used to treat painful diabetic
peripheral neuropathy. There is a knowledge gap, however, regarding the role of variable …